Clinical Study on Xianglian Huazhuo Granules to Block ''Inflammation-Carcinoma Transformation'' of Chronic Atrophic Gastritis

Phase 1

Recruiting

• Conditions: Atrophic gastritis

• Registration Number: ITMCTR2100005208
• Lead Sponsor: Hebei Provincial Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Meet the above-mentioned diagnostic criteria of Chinese and Western medicine;
(2) Atrophic gastritis was diagnosed by electronic gastroscopy and histopathology in our hospital before enrollment;
(3) Aged between 18 and 65 years old, no gender limit;
(4) Subjects are informed and voluntarily sign an informed consent form.

Exclusion Criteria

(1) Autoimmune gastritis (type A chronic atrophic gastritis);
(2) Patients with gastric and duodenal ulcers, upper gastrointestinal bleeding;
(3) Patients with severe dysplasia of gastric mucosa and suspected malignant transformation in mucosal pathology diagnosis;
(4) Patients with serious organic diseases, such as heart (heart function NYH?-?, myocardial infarction, severe arrhythmia, etc.), brain, liver, kidney, lung and blood system and other serious primary diseases;
(5) Those who have a history of allergies to the known drugs or ingredients in the study;
(6) Unable to cooperate with the study if combined with severe mental illness;
(7) Pregnant or lactating women;
(8) Patients who are participating in other drug clinical trials or stopping the last drug research for less than one month;
(9) Those who cannot cooperate with follow-up and investigation;
(10) Other circumstances deemed inappropriate by the researcher.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Histopathology;